Login

Biotech Firm Leases Block of Space in Boston’s Fenway Neighborhood

Gritstone bio Finalizes Deal To Take 74,000 Square Feet in Related Beal's Office Lab Complex
660 Beacon St. is part of Related Beal's One Kenmore Square redevelopment in Boston. (CoStar)
660 Beacon St. is part of Related Beal's One Kenmore Square redevelopment in Boston. (CoStar)
By Jackson Southworth
CoStar Research
October 1, 2021 | 3:37 P.M.

Gritstone bio, a clinical-stage biotechnology company headquartered in Emeryville, California, developing immunotherapy treatments for cancers and infectious diseases, signed a lease for a large block of space in Related Beal's One Kenmore Square development near Fenway Park in downtown Boston.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE